Henry Schein, Inc. (Nasdaq: HSIC), the leading provider of healthcare solutions to medical and dental practitioners, has signed an agreement to acquire a majority stake in Shield Healthcare, Inc. This move strengthens Henry Schein Medical’s care delivery model by adding Shield Healthcare’s direct-to-patient home medical products. This acquisition follows Henry Schein’s earlier Prism Medical Products LLC purchase, further expanding its presence in the homecare medical supplies market. With over $300 million in projected annual revenue, this deal bolsters Henry Schein’s medical business by delivering various supplies directly to patients, complementing its existing offerings. The agreement is expected to close in Q3 2023, with Shield Healthcare operating as part of Henry Schein Medical.
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that it has signed an agreement to acquire a majority ownership position in Shield Healthcare, Inc., a leading supplier of homecare medical products delivered directly to patients in their homes. The addition of Shield Healthcare will advance Henry Schein Medical’s continuum-of-care delivery model.
The Shield Healthcare agreement follows Henry Schein’s 2021 acquisition of Prism Medical Products LLC, and represents a further investment in the homecare medical supplies market delivering products directly to patients in their homes. With this acquisition, Henry Schein’s homecare medical products platform will have a revenue base of more than $300 million in annualized revenue. The Shield Healthcare transaction enhances Henry Schein’s existing medical business by delivering a wide range of products, including incontinence, urology, ostomy, enteral nutrition, advanced wound, and diabetes supplies, as well as continuous glucose monitoring devices, directly to patients in their homes.
Headquartered in Valencia, Calif., Shield Healthcare had 2022 net sales of approximately $180 million. Henry Schein expects the transaction to be neutral to 2023 non-GAAP earnings per share and accretive thereafter. Closing is subject to standard closing conditions and is expected to be completed in the third quarter of 2023. Financial terms were not disclosed.
“As the U.S. population ages and care increasingly moves into the home, Henry Schein is meeting this trend by enhancing our homecare medical products offering,” said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. “We are delighted to expand our presence in delivering medical products directly to patients through Shield Healthcare. Together, we share an unwavering commitment to customer satisfaction.”
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Shield Healthcare will operate as a part of Henry Schein Medical, which reported global sales for 2022 of $4.45 billion. The current owners of Shield Healthcare, including members of the company’s management team, will retain the remaining minority ownership position in the company.
Source: BioSpace